Annual report pursuant to Section 13 and 15(d)

17. Segment and Geographic Information (Tables)

v2.4.1.9
17. Segment and Geographic Information (Tables)
 12 Months Ended
Mar. 31, 2015
Segment Reporting [Abstract]  
Schedule of geographic sales
    Year Ended March 31,              
    2015     2014     $ Change     % Change  
United States   $ 1,978,000     $ 1,406,000     $ 572,000       41%
Mexico     5,053,000       3,758,000       1,295,000       34%
Europe and Rest of the World     2,908,000       2,046,000       862,000       42%
      9,939,000       7,210,000       2,729,000       38%
Product license fees and royalties     3,056,000       5,513,000       (2,457,000 )     (45% )
Total   $ 12,995,000     $ 12,723,000     $ 272,000       2%
Schedule of product license fees and royalties
    Year Ended March 31,              
    2015     2014     $ Change     % Change  
 Exeltis/Quinnova   $ 437,000     $ 807,000     $ (370,000 )     (46% )
 Onset/Precision     –       27,000       (27,000 )     (100% )
 Innovacyn     1,120,000       3,100,000       (1,980,000 )     (64% )
 Laboratorios Sanfer and More Pharma     1,499,000       1,501,000       (2,000 )     0%
 China distributor     –       78,000       (78,000 )     (100% )
 Total   $ 3,056,000     $ 5,513,000     $ (2,457,000 )     (45% )